CCL2 and metabolic dysfunction-associated steatohepatitis: Applying the previously published 5-gene signature (CCL2, DMRT2, GADD45B, IL1RN, and IL8)26 to our cohort, we found that this model was not able to accurately predict NASH or fibrosis stage (Fig. 2).